Significance of Some Hematological Parameters in Type 2 Diabetic Patients in the Enugu State University of Science and Technology Teaching Hospital, Enugu State, Nigeria
Alphonsus Ogbonna Ogbuabor, Juliet Ada Chineke, Silas Anayo Ufelle
Asian Hematology Research Journal · pp. 127–132 · Published 15 Sep 2022
Abstract
Background: Diabetes mellitus has over the years become a public health challenge and a complex disease which is characterized by chronic hyperglycemia that results in microvascular and macrovascular complications. Aim: The present study was designed to determine the hematological profile of type 2 diabetic (T2DM) patients in Enugu State University of Science and Technology Teaching Hospital, Enugu State, Nigeria. Methods: A total of 240 subjects comprising 120 T2DM (60 males and 60 females) aged 20-55 years and 120 apparently healthy age and gender-matched controls were recruited for the study. Blood sample (5.0ml) was collected from each subject for the analyses of the hematological parameters using Mindray 530 BC automated analyzer, Mindray Japan. The data was analysed using T-test and level of significance set at p<0.05. Results: The result revealed significantly decreased Mean Cell Volume (MCV) (86.54 + 0.85) in the T2DM subjects compared to the controls (89.88 + 1.09) and significantly increased Basophil count (0.93 + 0.09) in the T2DM subjects compared to the controls (0.22 + 0.03). Conclusion: These findings supports the claim for alterations in hematological profile of T2DM patients.
Cited by 0
No indexed citations yet.
Related research
- Influence of Vitamin D Level on Diabetic Dyslipidemia — shares topic coverage
- Prevalence of Non-Communicable Diseases in Patients with Type 2 Diabetes Mellitus in Egypt; A Retrospective Survey — shares topic coverage
- No Association between Helicobacter Pylori Infection and Type 2 Diabetes Mellitus; A Case-control Study in the North-Western Part of Ghana — shares topic coverage
- Relationship between Body Mass Index and Low-Density Lipoprotein and Triglycerides in Type 2 Diabetes Mellitus Patients — shares topic coverage
- Clinical Case Series on Assessment of Therapeutic Efficacy of Saroglitazar in MASLD Patients — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.